Nutraplus starts production of Lumefantrine at Tarapur plant

Published On 2016-01-19 02:59 GMT   |   Update On 2016-01-19 02:59 GMT

New Delhi: Pharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra."Previously company was engaged in the manufacturing of intermediate of the same drug... and was selling to various pharma companies," Nutraplus India said in a filing to BSE.Now, it is manufacturing the final end product at the company's...

Login or Register to read the full article
New Delhi: Pharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.

"Previously company was engaged in the manufacturing of intermediate of the same drug... and was selling to various pharma companies," Nutraplus India said in a filing to BSE.

Now, it is manufacturing the final end product at the company's new production facilities, it added.

Saying that this adds to the margins for the company, Nutraplus India said: "This is a forward integration and shall result in better margin."

The company expects to achieve full production capacities in next three months in the plant, it added.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News